Approximately 50% of childhood deafness is caused by mutations in specific genes. Autosomal recessive loci account for approximately 80% of nonsyndromic genetic deafness 1 . Here we report the identification of a new transmembrane serine protease (TMPRSS3; also known as ECHOS1) expressed in many tissues, including fetal cochlea, which is mutated in the families used to describe both the DFNB10 and DFNB8 loci. An 8-bp deletion and insertion of 18 monomeric (∼68-bp) β-satellite repeat units, normally present in tandem arrays of up to several hundred kilobases on the short arms of acrocentric chromosomes, causes congenital deafness (DFNB10). A mutation in a spliceacceptor site, resulting in a 4-bp insertion in the mRNA and a frameshift, was detected in childhood onset deafness (DFNB8). This is the first description of β-satellite insertion into an active gene resulting in a pathogenic state, and the first description of a protease involved in hearing loss.
The DFNB10 critical region and TMPRSS3. a, A map of the DFNB10 critical region in chromosome 21q22.3. The positions of the microsatellite markers defining the DFNB10 and DFNB8 critical region in 21q22.3 are shown. The BAC contig between markers 1016E7.CA60 and 1151C12.GT45 is shown, with six known genes (ABCG1, TFF3, TFF2, TFF1, PDE9A, NDUVF3) and seven novel genes (ZNF295, UMODL1, TMPRSS3, UBASH3A, TSGA2, SLC37A1, WDR4) mapping to the critical region. b, TMPRSS3 contains 13 exons (boxes) spanning 24 kb. c, There are four different transcripts, TMPRSS3a-d (coding regions in boxes, noncoding regions indicated by narrow box). d, A schematic of the TMPRSS3 protein showing the transmembrane (TM), LDLRA, SRCR and protease domains and their position in the 454-aa peptide. e, Expression analysis of the TMPRSS3 transcripts. RT-PCR specific to the TMPRSS3a-d transcripts were performed on cDNA from 27 human tissues and fetal cochlea as indicated.
Insertion of β-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness 1 (Fig. 1c) .
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Northern-blot analysis showed weak expression of the 2.4-and 1.4-kb TMPRSS3a and TMPRSS3d transcripts (data not shown). Semi-quantitative RT-PCR revealed that all four transcripts show distinct patterns of expression, but TMPRSS3a is the most abundantly and widely expressed transcript, including in fetal cochlea (Fig. 1e) .
The putative peptide encoded by TMPRSS3a contains transmembrane (TM), low-density-lipoprotein receptor A (LDLRA), scavenger-receptor cysteine-rich (SRCR) and serine protease domains (Fig. 1d ) similar to other proteases, including that encoded by the homologous gene TMPRSS2, which also maps on 21q, centromeric to the DFNB10 critical region 10 . The serine protease domain (residues 217-444) is compatible with the S1 family of the PA clan of serine-type peptidases (serine or cysteine nucleophile; catalytic residues in the order His, Asp, Ser (or Cys) in sequence; all endopeptidases) for which the prototype is chymotrypsin 11 , and shows between 45 and 38% identity with other transmembrane serine proteases (Fig. 1f) .
As no recognizable leader sequence precedes the predicted hydrophobic TM domain, TMPRSS3 is likely to be a type II integral membrane protein with a cytosolic amino terminus and an extracellular protease domain, similar to other transmembrane proteases 12 . The LDLRA domain, which contains six disulfidebound cysteines (C72, C79, C85, C92, C98 and C107), was originally found in the low density lipoprotein receptor as the binding site for low-density lipoprotein and calcium 13 , and has subsequently been described in numerous extracellular and membrane proteins. SRCR domains linked to serine protease domains have been reported in secreted or membrane-bound molecules with diverse biological roles in development and immunity 14 . The LDLRA and SRCR domains of TMPRSS3 may be involved in binding with extracellular molecules or the cell surface. The putative peptides encoded by the TMPRSS3b and TMPRSS3c transcripts contain only half of the SRCR domain, whereas the 15 .
Direct sequencing of all 13 exons of TMPRSS3 (PCR amplified from DNA samples from the Palestinian DFNB10 and Pakistani DFNB8 families 2,4,5 and controls) detected two sequence variants in the Palestinian/DFNB10 family (changes 4 and 5; Table 1 ). Amplification of exon 11 of TMPRSS3 from a DFNB10 sample resulted in a 1.7-kb product instead of the 476-bp product that was amplified from normal controls. Southernblot and PCR-assay analyses of exon 11 of TMPRSS3 showed that the size of the insertion does not vary between family members or generations (data not shown), unlike fragile sites and repeatexpansion disorders 16 . Eight affected individuals were homozygous for the 1.7-kb product and 13 obligate carriers had one copy. The insertion segregated with the phenotype (Fig. 2a,b) . Sequence analysis revealed a complex rearrangement with the deletion of 8 bp and the insertion of 18 complete β-satellite repeat monomers with 10 and 2 bp derived from β-satellite repeats at the 5´ and 3´ ends of the rearrangement, respectively (Fig. 2c) . The sequences of the 18 β-satellite monomers, although highly conserved, are also highly variable (52-93% divergence between repeats; Fig. 3a) . Monomeric, approximately 68-bp repetitive units of β-satellites (or Sau3A repeats) have been detected on the short arms of all human acrocentric chromosomes and chromosomes 1, 9 (centromeric), 19p and Y (refs. [17] [18] [19] . At least four families of β-satellites have been defined 19 and the β-satellite insertion into TMPRSS3 is likely to be derived from either p21β2 or p21β7 repeats.
Using two-color FISH, we detected TMPRSS3 signal only on chromosome 21q22.3, and β-satellites at the described localizations in normal chromosomes (data not shown). Colocalization was observed at 21q22.3 on chromosomes 21 derived from individuals heterozygous and homozygous for the insertion (Fig. 3b) .
The mobile nature of repetitive sequences on the short arms of acrocentric chromosomes is well documented 20 . Circular extrachromosomal molecules present in many eukaryotic cells, small polydisperse circular DNAs (spcDNA), may contain β-satellites 21 or other repeats present on the short arms of human acrocentric chromosomes (for review, see ref. 22) , and are probably produced by unequal homologous recombination between or within repetitive sequences. The insertion into TMPRSS3 in the DFNB10 family may have arisen by recombination of spcDNA containing β-satellites with a region of minimal homology spanning exon 11 of TMPRSS3 (Fig. 3c,d ). Although chromosomal rearrangements involving β-satellites have been described 23, 24 , this is the first description of β-satellite insertion into an active gene resulting in a pathogenic state.
Three TMPRSS3 sequence variants were observed in homozygosity in the Pakistani/DFNB8 family 2 (changes 1, 2 and 6; Table  1 ). A G→A substitution at IVS4-6, whose inheritance was consistent with deafness in branches 3 and 4 of the DFNB8 family, creates an alternative splice-acceptor site (Fig. 4a,b) and was observed in 1 of 160 Muslim Indians and none of 30 European chromosomes. Haplotype analysis on the heterozygous, hearing individual with IVS4-6G→A, and his/her spouse and child, with 4 intragenic TMPRSS3 SNPs (changes 1, 3, 4 and 6; Table 1 ) was consistent with a single mutational origin of IVS4-6G→A.
We next assessed the effect of IVS4-6G→A on splicing in vitro (Fig. 4b) . RT-PCR and sequencing revealed a 4-bp insertion between exons 4 and 5 (Fig. 4c,d) , consistent with the use of the putative splice acceptor site created by IVS4-6G→A. We screened 179 cloned RT-PCR products from an affected individual with an oligonucleotide that mimics the normal splice junction and one that includes the insertion. We found no hybridization with the 'normal' probe. Thus IVS4-6G→A can be considered to be a pathogenic mutation. Mutations in spliceacceptor sites that allow some normal splicing often result in 25 . In vivo, the IVS4-6G→A mutation in the DFNB8 family may allow limited normal splicing, and thus some normal TMPRSS3 protein, accounting for the phenotypic difference between the DFNB8 and DFNB10 families.
Many human disorders such as hereditary pancreatitis (PRSS1, MIM 167800) and coagulation factor deficiencies (factors VII, IX, X and XII) are due to deficiency of serine proteases. This, however, is the first description of a protease involved in hearing loss. The phenotypic differences between the two families studied here may imply that TMPRSS3 polymorphisms resulting in or associated with reduced expression or slightly abnormal function might be involved in age-related hearing loss, the most common form of hearing loss. The sensorineural hearing loss in both families with TMPRSS3 mutations implies defects in the inner ear. TMPRSS3 expression was demonstrated in fetal cochlea and many other tissues. TMPRSS3 may be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. The levels of total protein in endolymph are extremely low, but endolymph proteins show a prominence of glycosylated acidic proteins and turnover of these proteins may require specific proteases 26 .
Methods
Sample collection. The DFNB10 family (BT117) is a large, inbred, Palestinian family from a small town in Israel 4 . Pure-tone audiometric tests showed profound hearing loss in all affected individuals, without any hearing remnants, at a level of 75-80 decibels. Sensorineural deafness was confirmed in one-week-old twin girls by a brain stem-evoked potential (BERA) test. Blood samples were obtained from 36 hearing and 16 deaf individuals after obtaining informed consent and in accordance with institutional guidelines for human subjects.
The DFNB8 family is a large, consanguineous kindred from Pakistan 2 . Pure-tone audiometric tests, between 125 and 8,000 Hz up to 120 dB, revealed a maximum audio threshold in both ears of affected individuals of 105 dB at 1,000 Hz. Onset of hearing-related problems was between 10 and 12 y of age with profound hearing loss evident at 14 to 16 y. We obtained blood samples from 16 hearing and 8 deaf individuals after obtaining informed consent and in accordance with institutional guidelines for human subjects.
Bacterial clone contigs, genomic sequencing and isolation of TMPRSS3 cDNAs. A BAC/cosmid contig spanning MX1-D21S171 was constructed (see http://www.dmb.med.keio.ac.jp/seqpub/map/APECED.html). Genomic sequencing and analysis was as described 9 , and primers were designed to predicted exons (Table B , see http://genetics.nature.com/supplementary_info/). We amplified TMPRSS3 cDNA fragments with primer pairs TM1-F/TM1-R and TM2-F/TM2-R. We carried out 5´-and 3´-RACE with primer pairs TMRA-R1/AP1, TMRA-R2/AP2, TMRA-F1/AP1 and TMRA-F2/AP2. RT-PCR was carried out on thymus, spleen, lymph node, liver and placenta cDNA pools (MTC cDNA and Marathon-Ready cDNA, Clontech) using 35 cycles of 94 °C for 30 s, 65 °C for 1 min, and 72 °C for 2 min. PCR products were cloned into pBluescript II(SK+) (Stratagene) and sequenced. The sequence of predicted proteins of TMPRSS3 were analyzed using web-based tools including TMPRED (transmembrane prediction; http://ulrec3. unil.ch/software/TMPRED_form.html), and domain searches using the Pfam databases (http://www.sanger.ac.uk/Software/Pfam/search.shtml).
Multiple-tissue cDNA panel and northern-blot analysis. Expression analysis of TMPRSS3 was performed using the Human Multiple Tissue cDNA (MTC) panels (Clontech; I, II, fetal, and immune system panels) containing cDNAs from 27 human tissues and a cDNA prepared from fetal cochlea (18 weeks) mRNA. TMPRSS3 cDNAs were amplified with primer pairs TMa-F/TMabc-R (TMPRSS3a), TMb-F/TMabc-R (TMPRSS3b), TMc-F/TMabc-R (TMPRSS3c) and TM1-F/TMd-R (TMPRSS3d) using 20 pg of each cDNA as template, whereas the control PCR (a G3PDH amplimer) was amplified from 2 pg of cDNA. Northern blots containing 2 µg poly(A) + RNA from 23 different adult human tissues (Clontech Human MTN Blots 1-3) were hybridized with a 32 P-labeled probe (nt 1-517 of TMPRSS3a).
Mutation analyses. We determined the genomic structure of TMPRSS3 by comparing the genomic sequence with the cDNA sequences. Each TMPRSS3 exon and each flanking regions were amplified from patient and unrelated control DNAs (for primers see Table C , http://genetics.nature. com/supplementary_info/) and analysed as described 6 . PCR products containing exons 4 and 5 were amplified from a DFNB8 and a normal sample and the fragments were cloned into the exon-trapping vector pSPL3 (Gibco-BRL). Transfections, RNA isolation and RT-PCR were performed as described 27 between oligonucleotides 7614-TMP4eF (5´-GCT CATCCTTTAAGTGTATCG-3´) and 7615-TMP5eR (5´-ATGGTCTTCCAC GAAGCAGCTG-3´). Products were cloned into pTOPO (Invitrogen) and the 4-nt insertion was assayed by colony hybridization with oligonucleotides 7737-E4E5con (5´-AGTACCGCTGTGTCCGGGT-3´, normal) and 7738-E4E5deaf (5´-CCGCTGTGCCAGTCCGGGT-3´, mutant 4-nt underlined).
FISH analyses. BAC KB169B4 (containing TMPRSS3) and the mutant exon 11 PCR product containing 18 β-satellite repeats were labeled using the Biotin and DIG-nick translation mixes (Roche), respectively, and detected with Alexa Fluor 568 conjugate of Streptavidin (Molecular Probes) and sheep-anti-digoxigenin-fluorescin antibodies (Roche), respectively. Metaphase spreads were prepared using cultured lymphoblastic cells (from normal, heterozygote and affected individuals) and hybridized with a mixture of both probes using ChromaHyb 600 hybridization buffer (Quantum Biotechnologies).
GenBank accession numbers. Genomic sequence of BAC KB169B4, AP001623; human TMPRSS3a, TMPRSS3b, TMPRSS3c and TMPRSS3d cDNAs, AB038157, AB038158, AB038159 and AB038160, respectively.
